Health Effects Associated With Pre- and Perinatal Exposure to Arsenic

• Published in: Frontiers in genetics Vol. 12; p. 664717
• Main Authors: Martinez, Victor D, Lam, Wan L
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 29-09-2021
• Subjects: arsenic; DNA methylation; epigenetics; fetal development; Genetics; in utero exposure; DNA methylation; genetics; arsenic; in utero exposure; epigenetics; fetal development
• ISSN: 1664-8021; 1664-8021
• DOI: 10.3389/fgene.2021.664717

Inorganic arsenic is a well-established human carcinogen, able to induce genetic and epigenetic alterations. More than 200 million people worldwide are exposed to arsenic concentrations in drinking water exceeding the recommended WHO threshold (10μg/l). Additionally, chronic exposure to levels below this threshold is known to result in long-term health effects in humans. The arsenic-related health effects in humans are associated with its biotransformation process, whereby the resulting metabolites can induce molecular damage that accumulates over time. The effects derived from these alterations include genomic instability associated with oxidative damage, alteration of gene expression (including coding and non-coding RNAs), global and localized epigenetic reprogramming, and histone posttranslational modifications. These alterations directly affect molecular pathways involved in the onset and progression of many conditions that can arise even decades after the exposure occurs. Importantly, arsenic metabolites generated during its biotransformation can also pass through the placental barrier, resulting in fetal exposure to this carcinogen at similar levels to those of the mother. As such, more immediate effects of the arsenic-induced molecular damage can be observed as detrimental effects on fetal development, pregnancy, and birth outcomes. In this review, we focus on the genetic and epigenetic damage associated with exposure to low levels of arsenic, particularly those affecting early developmental stages. We also present how these alterations occurring during early life can impact the development of certain diseases in adult life.